Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).   “As with all drugs, FDA continues to ...

With the benefits rivaling some drugs, experts said cancer centers and insurance plans should consider making exercise ...

The FDA rolled out its agency-wide AI tool weeks ahead of schedule, on Monday offering a look at the technology and how it ...

Health news and commentary gathered by MedPage Today staff ...

“There’s not a lot of time and effort spent on figuring out what is the actual question,” said Gary Wolf, founder of ...

Dr. Marty Makary, the Johns Hopkins surgeon and professor whom President Donald Trump tapped to lead the U.S. Food and Drug Administration, says it’s up to patients and their doctors whether they ...

(Reed, 4/3) Stat: FDA's Marty Makary Focuses On MAHA, Not Agency Plans In Speech ... The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold ...

People with type 1 diabetes require insulin to live, while those with type 2 diabetes use insulin and other medications to ...

Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story RFK Jr. ends ...

The FDA Commissioner also promoted a report from the Make America Healthy Again Commission, which President Donald Trump's ...